Form 4 for HCWB HCW Biologics Inc.
Accepted 2022-09-12 00:00:00 ET · period of report 2022-09-08 · accession 0001209191-22-049469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-12 | 2022-09-08+ | HCWB | Wong Hing C | CEO, Dir | P - Purchase | $2.69 | +10.0K | 15.30M | +0.1% | +$26.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-09 | P | A | 6,000 | $2.70 | 15,306,468 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-08 | P | A | 4,000 | $2.67 | 15,300,468 | D | — | — |